|
Delayed
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-4.49% | -0.54% |
| 22-03-28 | Novelion Therapeutics Inc. Announces Final Cash Distribution, Payable on or About March 31, 2022 | CI |
| 20-01-16 | Novelion Therapeutics Inc. Announces Management Changes | CI |
| Market Cap | 13.85M 11.95M 11.26M 10.27M 19.17M 1.31B 19.32M 133M 51.69M 669M 51.99M 50.86M 2.2B | P/E 2017 |
-0.46x | P/E 2018 | -0.15x |
|---|---|---|---|---|---|
| Enterprise Value | 317M 274M 258M 235M 439M 30.12B 442M 3.05B 1.18B 15.32B 1.19B 1.16B 50.35B | EV / Sales 2017 |
1,887,512x | EV / Sales 2018 | 2,447,567x |
| Free-Float |
-
| Yield 2017 * |
-
| Yield 2018 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/9/20 | Edgepoint Investment Group, Inc.
| Buy | Company | 1,317 | 0.0067% | |
| 4/9/20 | Edgepoint Investment Group, Inc.
| Other | Company | 0 | 0% | - |
| 4/9/20 | Edgepoint Investment Group, Inc.
| Sell | Company | 750,000 | 3.8228% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 138.44 119.48 112.54 102.68 191.64 13.15K 193.11 1.33K 516.76 6.69K 519.82 508.47 21.98K | 130.43 112.57 106.03 96.74 180.56 12.39K 181.94 1.26K 486.88 6.3K 489.76 479.06 20.71K |
| Net income | -127M -109M -103M -93.98M -175M -12.03B -177M -1.22B -473M -6.12B -476M -465M -20.11B | -108M -93.49M -88.06M -80.35M -150M -10.29B -151M -1.04B -404M -5.23B -407M -398M -17.2B |
| Net Debt | 203M 175M 165M 151M 281M 19.29B 283M 1.95B 758M 9.81B 763M 746M 32.24B | 303M 262M 247M 225M 420M 28.8B 423M 2.92B 1.13B 14.65B 1.14B 1.11B 48.15B |
Employees
-
Sector
-
- Stock Market
- Stocks
- NVLNF Stock
Select your edition
All financial news and data tailored to specific country editions
